US Bancorp’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.32M | Sell |
5,330
-298
| -5% | -$203K | ﹤0.01% | 740 |
|
|
2026
Q1 | $4.35M | Buy |
5,628
+81
| +1% | +$62K | 0.01% | 637 |
|
|
2025
Q4 | $4.28M | Sell |
5,547
-155
| -3% | -$105K | 0.01% | 645 |
|
|
2025
Q3 | $3.21M | Buy |
5,702
+215
| +4% | +$122K | ﹤0.01% | 727 |
|
|
2025
Q2 | $2.88M | Sell |
5,487
-858
| -14% | -$479K | ﹤0.01% | 749 |
|
|
2025
Q1 | $4.02M | Buy |
6,345
+279
| +5% | +$192K | 0.01% | 635 |
|
|
2024
Q4 | $4.32M | Buy |
6,066
+1,078
| +22% | +$905K | 0.01% | 625 |
|
|
2024
Q3 | $5.24M | Sell |
4,988
-175
| -3% | -$195K | 0.01% | 573 |
|
|
2024
Q2 | $5.43M | Buy |
5,163
+153
| +3% | +$148K | 0.01% | 557 |
|
|
2024
Q1 | $4.82M | Buy |
5,010
+69
| +1% | +$65.6K | 0.01% | 591 |
|
|
2023
Q4 | $4.34M | Buy |
4,941
+310
| +7% | +$255K | 0.01% | 606 |
|
|
2023
Q3 | $3.81M | Buy |
4,631
+59
| +1% | +$46.4K | 0.01% | 610 |
|
|
2023
Q2 | $3.29M | Sell |
4,572
-536
| -10% | -$413K | 0.01% | 652 |
|
|
2023
Q1 | $4.2M | Buy |
5,108
+168
| +3% | +$127K | 0.01% | 590 |
|
|
2022
Q4 | $3.56M | Sell |
4,940
-843
| -15% | -$622K | 0.01% | 630 |
|
|
2022
Q3 | $3.98M | Buy |
5,783
+74
| +1% | +$46.6K | 0.01% | 561 |
|
|
2022
Q2 | $3.38M | Sell |
5,709
-289
| -5% | -$188K | 0.01% | 630 |
|
|
2022
Q1 | $4.19M | Buy |
5,998
+37
| +0.6% | +$23.4K | 0.01% | 613 |
|
|
2021
Q4 | $3.77M | Buy |
5,961
+37
| +0.6% | +$22.7K | 0.01% | 670 |
|
|
2021
Q3 | $3.58M | Sell |
5,924
-187
| -3% | -$116K | 0.01% | 661 |
|
|
2021
Q2 | $3.41M | Buy |
6,111
+93
| +2% | +$47.1K | 0.01% | 693 |
|
|
2021
Q1 | $2.85M | Buy |
6,018
+626
| +12% | +$305K | 0.01% | 722 |
|
|
2020
Q4 | $2.6M | Buy |
5,392
+831
| +18% | +$449K | 0.01% | 712 |
|
|
2020
Q3 | $2.55M | Buy |
4,561
+1,302
| +40% | +$789K | 0.01% | 667 |
|
|
2020
Q2 | $2.03M | Sell |
3,259
-252
| -7% | -$143K | 0.01% | 716 |
|
|
2020
Q1 | $1.71M | Sell |
3,511
-239
| -6% | -$98.6K | 0.01% | 714 |
|
|
2019
Q4 | $1.41M | Buy |
3,750
+94
| +3% | +$31.6K | ﹤0.01% | 905 |
|
|
2019
Q3 | $1.01M | Sell |
3,656
-64
| -2% | -$18.9K | ﹤0.01% | 1022 |
|
|
2019
Q2 | $1.16M | Sell |
3,720
-1,719
| -32% | -$572K | ﹤0.01% | 1009 |
|
|
2019
Q1 | $2.23M | Buy |
5,439
+13
| +0.2% | +$5.35K | 0.01% | 726 |
|
|
2018
Q4 | $2.03M | Sell |
5,426
-617
| -10% | -$226K | 0.01% | 734 |
|
|
2018
Q3 | $2.44M | Buy |
6,043
+66
| +1% | +$25.1K | 0.01% | 731 |
|
|
2018
Q2 | $2.06M | Sell |
5,977
-320
| -5% | -$100K | 0.01% | 791 |
|
|
2018
Q1 | $2.17M | Buy |
6,297
+133
| +2% | +$46.3K | 0.01% | 762 |
|
|
2017
Q4 | $2.32M | Buy |
6,164
+599
| +11% | +$243K | 0.01% | 742 |
|
|
2017
Q3 | $2.49M | Buy |
5,565
+420
| +8% | +$200K | 0.01% | 708 |
|
|
2017
Q2 | $2.53M | Buy |
5,145
+862
| +20% | +$377K | 0.01% | 680 |
|
|
2017
Q1 | $1.66M | Sell |
4,283
-152
| -3% | -$56.3K | 0.01% | 849 |
|
|
2016
Q4 | $1.63M | Buy |
4,435
+231
| +5% | +$87.8K | 0.01% | 841 |
|
|
2016
Q3 | $1.69M | Sell |
4,204
-203
| -5% | -$81.4K | 0.01% | 792 |
|
|
2016
Q2 | $1.54M | Buy |
4,407
+431
| +11% | +$166K | 0.01% | 807 |
|
|
2016
Q1 | $1.43M | Buy |
3,976
+1
| +0% | +$412 | 0.01% | 813 |
|
|
2015
Q4 | $2.16M | Buy |
3,975
+340
| +9% | +$184K | 0.01% | 678 |
|
|
2015
Q3 | $1.69M | Buy |
3,635
+429
| +13% | +$230K | 0.01% | 751 |
|
|
2015
Q2 | $1.64M | Sell |
3,206
-1,713
| -35% | -$836K | 0.01% | 803 |
|
|
2015
Q1 | $2.22M | Buy |
4,919
+1,346
| +38% | +$570K | 0.01% | 686 |
|
|
2014
Q4 | $1.47M | Buy |
3,573
+45
| +1% | +$17.7K | 0.01% | 823 |
|
|
2014
Q3 | $1.27M | Buy |
3,528
+32
| +0.9% | +$10.7K | 0.01% | 874 |
|
|
2014
Q2 | $987K | Buy |
3,496
+230
| +7% | +$68.2K | ﹤0.01% | 1007 |
|
|
2014
Q1 | $980K | Buy |
3,266
+991
| +44% | +$305K | ﹤0.01% | 990 |
|
|
2013
Q4 | $626K | Buy |
2,275
+722
| +46% | +$208K | ﹤0.01% | 1175 |
|
|
2013
Q3 | $485K | Buy |
1,553
+747
| +93% | +$196K | ﹤0.01% | 1251 |
|
|
2013
Q2 | $181K | Buy |
+806
| New | +$188K | ﹤0.01% | 1695 |
|
Other funds holding REGN
US Bancorp's REGN Position: Q2 2026 in Review
US Bancorp reduced its Regeneron Pharmaceuticals (REGN) stake by 5.3% in Q2 2026, selling an estimated $203K and leaving 5,330 shares worth $3.32M. The position accounts for ﹤0.01% of the portfolio, ranked #740.
US Bancorp first reported a position in REGN in Q2 2013 and has held it in 53 quarters since. The position peaked at $5.43M in Q2 2024. 1,332 funds tracked by Wall St. Rank hold REGN as of Q2 2026.
- US Bancorp held 5,330 shares of Regeneron Pharmaceuticals worth $3.32M as of Q2 2026.
- US Bancorp sold 298 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $203K.
- Regeneron Pharmaceuticals made up ﹤0.01% of US Bancorp's portfolio in Q2 2026, its #740 holding.
- US Bancorp first reported a position in Regeneron Pharmaceuticals in Q2 2013 and has held it in 53 quarters since.
- US Bancorp's Regeneron Pharmaceuticals position peaked at $5.43M in Q2 2024.
- 1,332 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.
Based on US Bancorp's 13F filing for Q2 2026, filed 12 Aug 2026.